·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ Çѹ̾àÇ°, ¾Æ½ºÇǸ°¡¤PPI º¹ÇÕÁ¦ ¡®¶ó½ºÇǸ°¡¯ Ãâ½Ã ±â»çÀÔ·Â : 24.02.02 11:39:30 0 °¡ ÇÃÄ£Ãß°¡ ¶ó½ºÇǸ°Ä¸½¶ 100/5mg Ãâ½Ã¡¦ÇÑ¹Ì µ¶ÀÚ±â¼ú ¡®Æú¸®Ä¸¡¯ Àû¿ë [µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Çѹ̾àÇ°Àº ¾Æ½ºÇǸ° 100mg¿Í ¶óº£ÇÁ¶óÁ¹ 5mg º¹ÇÕÁ¦ÀÎ ¶ó½ºÇǸ°À» Ãâ½ÃÇÑ´Ù°í 2ÀÏ ¹àÇû´Ù. Çѹ̾àÇ°¿¡ µû¸£¸é ¶ó½ºÇǸ°Àº Æú¸®Ä¸ ±â¼úÀ» Àû¿ëÇÑ ´öºÐ¿¡ ¼ººÐ °£ »óÈ£ÀÛ¿ëÀ» ÁÙÀ̸鼵µ µ¶¸³Àû ¿ëÃâ·Î ¾à¹°Èí¼ö°¡ ÀϾ´Â ÀåÁ¡ÀÌ ÀÖ´Ù. PPI Á¦Á¦ÀÎ ¶óº£ÇÁ¶óÁ¹ ¼ººÐ¿¡´Â ¹æ½ÀÄÚÆÃÀ» ÁøÇàÇØ ¾ÈÁ¤¼ºÀ» ´õÇß´Ù. Æú¸®Ä¸Àº µÎ ¼ººÐ °¢°¢ÀÇ ¹æÃâ ÆÐÅÏÀ» ±×´ë·Î À¯ÁöÇÏ¸é¼ ¾à¹° °£ »óÈ£ÀÛ¿ëÀ» ÃÖ¼ÒÈÇÑ Çѹ̾àÇ°ÀÇ µ¶ÀÚÀû Á¦Á¦ ±â¼úÀÌ´Ù. Çѹ̾àÇ° °ü°èÀÚ´Â ¡°È¸»çÀÇ µ¶ÀÚÀû Á¦Á¦±â¼ú·Î °³¹ßµÈ ¶ó½ºÇǸ°ÀÌ ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô ÇýÅÃÀ» µå¸®´Â Ä¡·áÁ¦°¡ µÉ ¼ö ÀÖÀ» °Í¡±À̶ó¸ç ¡°¾Æ½ºÇǸ°°ú PPI¸¦ °¢°¢ º¹¿ëÇÒ ¶§º¸´Ù °æÁ¦ÀûÀÌ¾î¼ º¸ÇèÀçÁ¤ Àý°¨¿¡µµ ±â¿©ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµÈ´Ù¡±°í ¸»Çß´Ù. ¼ÕÇü¹Î ±âÀÚ(shm@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · Çѹ̾àÇ°, '·Ñº£µ·' ¾Æ½Ã¾Æ¡¤¾ÆÇÁ¸®Ä« ÆÇ±Ç È¸¼ö · Çѹ̾àÇ° º¹Çսžà '¾Æ¸ðÀßź' ´©Àû ¸ÅÃâ 1Á¶¿ø µ¹ÆÄ · ÇѹÌ, Æĸ®¿¡Æ®5mg¼ Âø¾ÈÇÑ º¹ÇÕÁ¦ '¶ó½ºÇǸ°' Ãâ°Ý [Çѵ¶] MI ¸Å´ÏÀú/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/¸¶ÄÉÆÃ/µðÁöÅÐÇコÄÉ¾î ¿µ¾÷/IVD ¿µ¾÷/RA/Corporate Development/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç ¹Ù·Î°¡±â Áö¿¤Æĸ¶ °³¹ßº»ºÎ_»ç¾÷°³¹ßÆÀ, °³¹ßÆÀ ä¿ë °ø°í ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ÀǾàÇ° µµ¸Å»ó KGSPÇ°Áú°ü¸®¾à»ç´Ô ¸ðÁý ¹Ù·Î°¡±â Medical Information Associate ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â ¼¿ïÁö¹æ±³Á¤Ã» ÀϹÝÁ÷°ø¹«¿ø(¾à¹«ÁÖ»ç) °æ·Â°æÀïä¿ë½ÃÇè °ø°í ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѹ̾àÇ°, ¾Æ½ºÇǸ°¡¤PPI º¹ÇÕÁ¦ ¡®¶ó½ºÇǸ°¡¯ Ãâ½Ã URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çѹ̾àÇ°, ¾Æ½ºÇǸ°¡¤PPI º¹ÇÕÁ¦ ¡®¶ó½ºÇǸ°¡¯ Ãâ½Ã ±â»çÀÔ·Â : 24.02.02 11:39:30 0 °¡ ÇÃÄ£Ãß°¡ ¶ó½ºÇǸ°Ä¸½¶ 100/5mg Ãâ½Ã¡¦ÇÑ¹Ì µ¶ÀÚ±â¼ú ¡®Æú¸®Ä¸¡¯ Àû¿ë [µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Çѹ̾àÇ°Àº ¾Æ½ºÇǸ° 100mg¿Í ¶óº£ÇÁ¶óÁ¹ 5mg º¹ÇÕÁ¦ÀÎ ¶ó½ºÇǸ°À» Ãâ½ÃÇÑ´Ù°í 2ÀÏ ¹àÇû´Ù. Çѹ̾àÇ°¿¡ µû¸£¸é ¶ó½ºÇǸ°Àº Æú¸®Ä¸ ±â¼úÀ» Àû¿ëÇÑ ´öºÐ¿¡ ¼ººÐ °£ »óÈ£ÀÛ¿ëÀ» ÁÙÀ̸鼵µ µ¶¸³Àû ¿ëÃâ·Î ¾à¹°Èí¼ö°¡ ÀϾ´Â ÀåÁ¡ÀÌ ÀÖ´Ù. PPI Á¦Á¦ÀÎ ¶óº£ÇÁ¶óÁ¹ ¼ººÐ¿¡´Â ¹æ½ÀÄÚÆÃÀ» ÁøÇàÇØ ¾ÈÁ¤¼ºÀ» ´õÇß´Ù. Æú¸®Ä¸Àº µÎ ¼ººÐ °¢°¢ÀÇ ¹æÃâ ÆÐÅÏÀ» ±×´ë·Î À¯ÁöÇÏ¸é¼ ¾à¹° °£ »óÈ£ÀÛ¿ëÀ» ÃÖ¼ÒÈÇÑ Çѹ̾àÇ°ÀÇ µ¶ÀÚÀû Á¦Á¦ ±â¼úÀÌ´Ù. Çѹ̾àÇ° °ü°èÀÚ´Â ¡°È¸»çÀÇ µ¶ÀÚÀû Á¦Á¦±â¼ú·Î °³¹ßµÈ ¶ó½ºÇǸ°ÀÌ ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô ÇýÅÃÀ» µå¸®´Â Ä¡·áÁ¦°¡ µÉ ¼ö ÀÖÀ» °Í¡±À̶ó¸ç ¡°¾Æ½ºÇǸ°°ú PPI¸¦ °¢°¢ º¹¿ëÇÒ ¶§º¸´Ù °æÁ¦ÀûÀÌ¾î¼ º¸ÇèÀçÁ¤ Àý°¨¿¡µµ ±â¿©ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµÈ´Ù¡±°í ¸»Çß´Ù. ¼ÕÇü¹Î ±âÀÚ(shm@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · Çѹ̾àÇ°, '·Ñº£µ·' ¾Æ½Ã¾Æ¡¤¾ÆÇÁ¸®Ä« ÆÇ±Ç È¸¼ö · Çѹ̾àÇ° º¹Çսžà '¾Æ¸ðÀßź' ´©Àû ¸ÅÃâ 1Á¶¿ø µ¹ÆÄ · ÇѹÌ, Æĸ®¿¡Æ®5mg¼ Âø¾ÈÇÑ º¹ÇÕÁ¦ '¶ó½ºÇǸ°' Ãâ°Ý [Çѵ¶] MI ¸Å´ÏÀú/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/¸¶ÄÉÆÃ/µðÁöÅÐÇコÄÉ¾î ¿µ¾÷/IVD ¿µ¾÷/RA/Corporate Development/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç ¹Ù·Î°¡±â Áö¿¤Æĸ¶ °³¹ßº»ºÎ_»ç¾÷°³¹ßÆÀ, °³¹ßÆÀ ä¿ë °ø°í ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ÀǾàÇ° µµ¸Å»ó KGSPÇ°Áú°ü¸®¾à»ç´Ô ¸ðÁý ¹Ù·Î°¡±â Medical Information Associate ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â ¼¿ïÁö¹æ±³Á¤Ã» ÀϹÝÁ÷°ø¹«¿ø(¾à¹«ÁÖ»ç) °æ·Â°æÀïä¿ë½ÃÇè °ø°í ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѹ̾àÇ°, ¾Æ½ºÇǸ°¡¤PPI º¹ÇÕÁ¦ ¡®¶ó½ºÇǸ°¡¯ Ãâ½Ã URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çѹ̾àÇ°, ¾Æ½ºÇǸ°¡¤PPI º¹ÇÕÁ¦ ¡®¶ó½ºÇǸ°¡¯ Ãâ½Ã ±â»çÀÔ·Â : 24.02.02 11:39:30 0 °¡ ÇÃÄ£Ãß°¡ ¶ó½ºÇǸ°Ä¸½¶ 100/5mg Ãâ½Ã¡¦ÇÑ¹Ì µ¶ÀÚ±â¼ú ¡®Æú¸®Ä¸¡¯ Àû¿ë [µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Çѹ̾àÇ°Àº ¾Æ½ºÇǸ° 100mg¿Í ¶óº£ÇÁ¶óÁ¹ 5mg º¹ÇÕÁ¦ÀÎ ¶ó½ºÇǸ°À» Ãâ½ÃÇÑ´Ù°í 2ÀÏ ¹àÇû´Ù. Çѹ̾àÇ°¿¡ µû¸£¸é ¶ó½ºÇǸ°Àº Æú¸®Ä¸ ±â¼úÀ» Àû¿ëÇÑ ´öºÐ¿¡ ¼ººÐ °£ »óÈ£ÀÛ¿ëÀ» ÁÙÀ̸鼵µ µ¶¸³Àû ¿ëÃâ·Î ¾à¹°Èí¼ö°¡ ÀϾ´Â ÀåÁ¡ÀÌ ÀÖ´Ù. PPI Á¦Á¦ÀÎ ¶óº£ÇÁ¶óÁ¹ ¼ººÐ¿¡´Â ¹æ½ÀÄÚÆÃÀ» ÁøÇàÇØ ¾ÈÁ¤¼ºÀ» ´õÇß´Ù. Æú¸®Ä¸Àº µÎ ¼ººÐ °¢°¢ÀÇ ¹æÃâ ÆÐÅÏÀ» ±×´ë·Î À¯ÁöÇÏ¸é¼ ¾à¹° °£ »óÈ£ÀÛ¿ëÀ» ÃÖ¼ÒÈÇÑ Çѹ̾àÇ°ÀÇ µ¶ÀÚÀû Á¦Á¦ ±â¼úÀÌ´Ù. Çѹ̾àÇ° °ü°èÀÚ´Â ¡°È¸»çÀÇ µ¶ÀÚÀû Á¦Á¦±â¼ú·Î °³¹ßµÈ ¶ó½ºÇǸ°ÀÌ ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô ÇýÅÃÀ» µå¸®´Â Ä¡·áÁ¦°¡ µÉ ¼ö ÀÖÀ» °Í¡±À̶ó¸ç ¡°¾Æ½ºÇǸ°°ú PPI¸¦ °¢°¢ º¹¿ëÇÒ ¶§º¸´Ù °æÁ¦ÀûÀÌ¾î¼ º¸ÇèÀçÁ¤ Àý°¨¿¡µµ ±â¿©ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµÈ´Ù¡±°í ¸»Çß´Ù. ¼ÕÇü¹Î ±âÀÚ(shm@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · Çѹ̾àÇ°, '·Ñº£µ·' ¾Æ½Ã¾Æ¡¤¾ÆÇÁ¸®Ä« ÆÇ±Ç È¸¼ö · Çѹ̾àÇ° º¹Çսžà '¾Æ¸ðÀßź' ´©Àû ¸ÅÃâ 1Á¶¿ø µ¹ÆÄ · ÇѹÌ, Æĸ®¿¡Æ®5mg¼ Âø¾ÈÇÑ º¹ÇÕÁ¦ '¶ó½ºÇǸ°' Ãâ°Ý
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѹ̾àÇ°, ¾Æ½ºÇǸ°¡¤PPI º¹ÇÕÁ¦ ¡®¶ó½ºÇǸ°¡¯ Ãâ½Ã URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö